Open Accessibility Menu

Coronavirus (COVID-19) Vaccine Update Click here to learn more.

For information about COVID-19 or to view additional resources, please click here.

How to Reach Your Care Providers

ways to contact your gw obstetrics & gynecology providers

Questions or Concerns? Call 202.741.2500

PREGNANCY QUESTIONS / CONCERNS

  • Daytime hours (Mon, Tue, Thurs, Fri: 8:00 AM – 4:30 PM / Wed: 9:00 AM – 4:30 PM): press the prompt for the triage nurse
  • Evening/Night hours (4:30 PM – 8:00 AM): you will be connected to the answering service and then to the physician or midwife on call
  • Appointment scheduling – press the prompt for your provider

FOLLOWMYHEALTH PATIENT PORTAL

The GW Medical Faculty Associates personal health information system - We encourage you to sign up!

  • Appointment scheduling
  • Non-urgent pregnancy or health related questions - allow 48-72 hours for a response
  • Through the FollowMyHealth patient portal, you may also view your medical records, lab results and prescriptions. If you have not already signed up for the FollowMyHealth patient portal, please sign up at your next appointment.

To learn more or sign up for FollowMyHealth, please visit: gwdocs.com/followmyhealth.


URGENT PREGNANCY CONCERNS – WHAT TO DO?

Below is a list of some common pregnancy concerns that WE ASK you to call us about:

  • If you think you are in labor
  • If you are not feeling the baby move
  • Vaginal bleeding
  • Leaking of fluid
  • Fever
  • Sudden or persistent vomiting or diarrhea
  • Contractions or cramps before 37 weeks (the 9th month)

CALL! There is a physician and midwife on call 24/7 available to address your concerns. We would ALWAYS rather you call us and have everything be ok than for you to wait with a problem or health issue. DO NOT use FollowMyHealth or email with urgent concerns - this can delay your prompt evaluation and care.


BILLING AND INSURANCE

The global fee for a normal vaginal delivery without complications includes all routine pregnancy related office visits, vaginal delivery and the postpartum visit. The fee may not include Maternal Fetal Medicine specialty care, laboratory testing, ultrasounds, or additional visits due to complications of pregnancy. It may not include hospitalizations, anesthesia services for delivery, or pediatrician fees postnatally. These are additional services that are billed to your insurance carrier.

If you require a cesarean delivery, the surgeon and assistant surgeon have additional fees. Unfortunately, complications during a pregnancy or in delivery can occur. Any charges incurred for complications are not included in the global fee for a normal vaginal delivery. Office visits for non-pregnancy related issues such as colds or urinary tract infections are typically not covered by your “global” fee and will be charged as a separate visit outside the global fee. Some insurance companies have different fee structures for complications in pregnancy.

Please check with your insurance plan for your benefits and plan coverage, deductible amount and co-pays. If you have any questions about your bill, please call our billing office at 202.741.3560.

Conveniently Located

Clinical Trials

  • This study is looking at the relationship between sleep and perinatal mood disorders such as depression and anxiety. Participants will wear a wrist monitor like a fit bit for 10 days to help researchers gain information into sleep patterns during pregnancy and postpartum and will answer questionnaires about their mood.
  • Preterm birth is one of the leading causes of neonatal morbidity and mortality. One of the most significant risk factors is a history of a prior spontaneous preterm birth. Intramuscular progesterone is the only FDA approved medication for the prevention of recurrent preterm birth. Vaginal progesterone is not FDA approved for the prevention of recurrent preterm birth, but has been found to beneficial. Given the presence of trials demonstrating efficacy for both intramuscular and vaginal progesterone in the prevention of recurrent preterm birth, but limited information one being more superior to the other, we are performing a trial comparing vaginal progesterone and intramuscular progesterone for the prevention of recurrent spontaneous preterm birth in women with a history of prior spontaneous preterm birth.
  • [This study is no longer recruiting.] The SONATA Study is an FDA-approved clinical study designed to establish the safety and effectiveness of a new, investigational device to reduce heavy menstrual bleeding caused by uterine fibroids. The device, called the SONATA System, targets fibroids rather than treatment or removing the entire uterus. If effective, this device will provide an alternative to hysterectomy that is: incision-free, preserves the uterus, does not require general anesthesia and is an outpatient procedure.
  • Women with twin pregnancy who have a dilated (open) cervix detected on physical exam before 24 weeks are at increased risk for delivering their babies preterm (before 37 weeks gestation). Prematurity is associated with many complications for the babies including respiratory (breathing) problems, bleeding inside of the brain (a form of stroke), increased risk of infection, kidney, temperature and feeding problems. The primary objective of this study is to determine if physical exam indicated cerclage use reduces the incidence of spontaneous PTB in asymptomatic women with twin gestations with cervical dilation diagnosed on pelvic exam before 24 weeks of gestation.
  • Tranexamic acid was shown to significantly reduce risk of mortality when given to women with diagnosed postpartum hemorrhage in the recent Lancet WOMAN Trial.* The purpose of this study is to determine the optimal dose for using tranexamic acid to prevent postpartum hemorrhage during routine cesarean section. Women undergoing cesarean section will be eligible and must not have a history of blood clots or a known clotting condition. *http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31111-X/fulltext
  • In this study, we are developing non-invasive tools to identify early signs of abnormalities of the placental function using arterial spin labeling (ASL) based on fetal MRI. ASL is a particularly attractive method for early and safe monitoring during pregnancy given that ASL is completely non-invasive and does not require contrast agents or exposure to ionizing radiation. Our specific aim is to develop and validate placental perfusion imaging with substantially improved image quality and sensitivity to abnormalities.
  • This study is being performed at Children's National Health System. We are trying to understand how the normal fetus controls blood flow to the different parts of the body such as the lungs and brain. We will measure your baby's blood flow using the same ultrasound approach used by your obstetrician. We will test your baby's control of blood flow by measuring the responses to changes in your (the mom's), levels of oxygen and carbon dioxide. We will make these changes by asking you to breathe extra oxygen for short periods of time. If your obstetrician determines that your pregnancy is uncomplicated, you and your baby are eligible for this study.